|
Human
Papilloma Virus (HPV) ranks as one of the world’s major
Sexually Transmitted Diseases. Over 20 million Americans are
infected with this virus. Strains of HPV are known to cause
common skin warts, genital warts and are the cause of
nearly 100% of cervical carcinomas. More than 50% of
infected women are without symptoms and are unaware of their
infection, the potential seriousness of their illness, and
the possibility of transmitting the virus to their sexual
partners. In developed countries, cervical cancer ranks as
the 5th most frequent female malignancy and accounts for 7%
of all female cancers. In the USA, over 5000 women die each
year of cervical cancer caused by the HPV virus. In
developing countries, where 80% of the cases occur, the
problem is yet more severe.
At
present there is no effective drug available to prevent the
transmission of HPV. Doxovir-M™ is effective against HPV
both in vitro and in vivo. Redox Pharmaceutical Corporation
is engaged in studies seeking both a prophylactic and a
therapeutic application of Doxovir-M™ for Papillomavirus.
|
